癌症研究
雷达51
奥拉帕尼
表观遗传学
PARP抑制剂
DNA修复
合成致死
甲基转移酶
癌症
生物
肿瘤进展
肝癌
DNA损伤
组蛋白
医学
聚ADP核糖聚合酶
肝细胞癌
遗传学
DNA
甲基化
基因
聚合酶
作者
Tong Yu,Fan Wang,Songling Li,Wenyun Guo,Qianyu Li,Yifei Qian,Linfeng Li,Huifang Zhao,Yonglong Zhang,Wei‐Qiang Gao,Yanfeng Liu
出处
期刊:Hepatology
[Lippincott Williams & Wilkins]
日期:2023-08-09
卷期号:80 (1): 38-54
被引量:16
标识
DOI:10.1097/hep.0000000000000559
摘要
KMT5C played a vital role in promoting liver cancer progression by activating the DNA repair response. Our results revealed a novel therapeutic approach using the KMT5C inhibitor A196, concurrent with olaparib, as a potential HCC therapy.
科研通智能强力驱动
Strongly Powered by AbleSci AI